Different forms of adiponectin reduce the apoptotic and damaging effect of cigarette smoke extract on human bronchial epithelial cells

Cheng,Meng‑Yu; Liu,Hu; Zhang,Tie‑Mei; Xu,Jian‑Ying

doi:10.3892/etm.2016.3872

Different forms of adiponectin reduce the apoptotic and damaging effect of cigarette smoke extract on human bronchial epithelial cells

Authors:
- Meng‑Yu Cheng
- Hu Liu
- Tie‑Mei Zhang
- Jian‑Ying Xu
View Affiliations

Affiliations: Department of Respiratory Medicine, Dayi Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi 030032, P.R. China, Second Department of Respiratory Medicine, Jimo City People's Hospital, Qingdao, Shandong 266200, P.R. China
Published online on: November 4, 2016 https://doi.org/10.3892/etm.2016.3872
Pages: 4168-4174

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chronic obstructive pulmonary disease (COPD) is a common respiratory disease, in which adiponectin may serve an important role. The present study investigated the role of adiponectin in the apoptotic and damaging effect of cigarette smoke extract (CSE) on human bronchial epithelial cells (16HBECs). An MTT assay showed that CSE significantly inhibited the proliferation of 16HBECs (F=1808.88, P<0.01). The 16HBECs were treated with different concentrations of high molecular weight (HMW) adiponectin and globular domain (gAd) adiponectin and it was observed that HMW and gAd dose‑dependently inhibited the expression of tumor necrosis factor (TNF)‑α and interleukin (IL)‑8, and the generation of 4‑hydroxy‑nonenal and reactive oxygen species (ROS) in 16HBECs, thereby blocking the upregulating effect of CSE on these factors. However, the inhibitory effect of gAd on TNF‑α and IL‑8 expression was stronger compared with that of HMW, but the suppressing effect of HMW on ROS production was superior compared with that of gAd. Further testing of apoptosis indicated that CSE and HMW promoted the apoptosis of 16HBECs. However, such effects of HMW declined with an increase in concentration. In contrast, gAd showed an inhibitory effect on apoptosis and inhibited the occurrence of CSE‑induced apoptosis in a dose‑dependent manner. Therefore, the present study demonstrated that different forms of adiponectin may have different mechanisms of action, suggesting that further exploration of their effects may open a new avenue for the treatment of COPD.

View Figures

View References

1	Smolonska J, Wijmenga C, Postma DS and Boezen HM: Meta-analyses on suspected chronic obstructive pulmonary disease genes: A summary of 20 years' research. Am J Respir Crit Care Med. 180:618–631. 2009. View Article : Google Scholar : PubMed/NCBI
2	Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, et al: Prevalence of chronic obstructive pulmonary disease in China: A large, population-based survey. Am J Respir Crit Care Med. 176:753–760. 2007. View Article : Google Scholar : PubMed/NCBI
3	Decramer M, Janssens W and Miravitlles M: Chronic obstructive pulmonary disease. Lancet. 379:1341–1351. 2012. View Article : Google Scholar : PubMed/NCBI
4	Muro S: Cigarette smoking is the most important causal factor for developing chronic obstructive pulmonary disease (COPD). Nihon Rinsho. 69:1735–1740. 2011.(In Japanese). PubMed/NCBI
5	Løkke A, Lange P, Scharling H, Fabricius P and Vestbo J: Developing COPD: A 25 year follow up study of the general population. Thorax. 61:935–939. 2006. View Article : Google Scholar : PubMed/NCBI
6	Bush A: COPD: A pediatric disease. COPD. 5:53–67. 2008. View Article : Google Scholar : PubMed/NCBI
7	Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S and Carrozzi L: Definition, epidemiology and natural history of COPD. Eur Respir J. 30:993–1013. 2007. View Article : Google Scholar : PubMed/NCBI
8	Zhou Y, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Wang X, et al: COPD in Chinese nonsmokers. Eur Respir J. 33:509–518. 2009. View Article : Google Scholar : PubMed/NCBI
9	Miller M, Cho JY, Pham A, Ramsdell J and Broide DH: Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J Immunol. 182:684–691. 2009. View Article : Google Scholar : PubMed/NCBI
10	Tomoda K, Yoshikawa M, Itoh T, Tamak S, Fukuoka A, Komeda K and Kimura H: Elevated circulating plasma adiponectin in underweight patients with COPD. Chest. 132:135–140. 2007. View Article : Google Scholar : PubMed/NCBI
11	Chan KH, Yeung SC, Yao TJ, Ip MS, Cheung AH, Chan-Yeung MM and Mak JC: COPD Study Group of the Hong Kong Thoracic Society: Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 14:1193–1200. 2010.PubMed/NCBI
12	Miller M, Pham A, Cho JY, Rosenthal P and Broide DH: Adiponectin-deficient mice are protected against tobacco-induced inflammation and increased emphysema. Am J Physiol Lung Cell Mol Physiol. 299:L834–L842. 2010. View Article : Google Scholar : PubMed/NCBI
13	Daniele A, De Rosa A, Nigro E, Scudiero O, Capasso M, Masullo M, de Laurentiis G, Oriani G, Sofia M and Bianco A: Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease. Int J Biochem Cell Biol. 44:563–569. 2012. View Article : Google Scholar : PubMed/NCBI
14	Tilg H and Moschen AR: Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 6:772–783. 2006. View Article : Google Scholar : PubMed/NCBI
15	Wert SE: Does adiponectin play a role in pulmonary emphysema? Am J Physiol Lung Cell Mol Physiol. 294:L1032–L1034. 2008. View Article : Google Scholar : PubMed/NCBI
16	Su Y, Han W, Giraldo C, De Li Y and Block ER: Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol. 19:819–825. 1998. View Article : Google Scholar : PubMed/NCBI
17	Damiá Ade D, Gimeno JC, Ferrer MJ, Fabregas ML, Folch PA and Paya JM: A study of the effect of proinflammatory cytokines on the epithelial cells of smokers, with or without COPD. Arch Bronconeumol. 47:447–453. 2011. View Article : Google Scholar : PubMed/NCBI
18	Garrod R, Marshall J, Barley E, Fredericks S and Hagan G: The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD). Prim Care Respir J. 16:236–240. 2007. View Article : Google Scholar : PubMed/NCBI
19	Kode A, Yang SR and Rahman I: Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res. 7:1322006. View Article : Google Scholar : PubMed/NCBI
20	Chorostowska-Wynimko J: The role of inflammation in the pathogenesis of chronic obstructive pulmonary disease. Pol Merkur Lekarski. 17:203–207. 2004.(In Polish). PubMed/NCBI
21	Barnes PJ, Shapiro SD and Pauwels RA: Chronic obstructive pulmonary disease: Molecular and cellular mechanisms. Eur Respir J. 22:672–688. 2003. View Article : Google Scholar : PubMed/NCBI
22	Siasos G, Tousoulis D, Kollia C, Oikonomou E, Siasou Z, Stefanadis C and Papavassiliou AG: Adiponectin and cardiovascular disease: Mechanisms and new therapeutic approaches. Curr Med Chem. 19:1193–1209. 2012. View Article : Google Scholar : PubMed/NCBI
23	Bianco A, Mazzarella G, Tu'rchiarelli V, Nigro E, Corbi G, Scudiero O, Sofia M and Daniele A: Adiponectin: An attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD). Nutrients. 5:4115–4125. 2013. View Article : Google Scholar : PubMed/NCBI
24	Sull JW, Kim HJ, Yun JE, Park EJ, Kim G and Jee SH: Serum adiponectin is associated with smoking status in healthy Korean men. Endocr J. 56:73–78. 2009. View Article : Google Scholar : PubMed/NCBI
25	Kirdar S, Serter M, Ceylan E, Sener AG, Kavak T and Karadağ F: Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand J Clin Lab Invest. 69:219–224. 2009. View Article : Google Scholar : PubMed/NCBI
26	Summer R, Little FF, Ouchi N, Takemura Y, Aprahamian T, Dwyer D, Fitzsimmons K, Suki B, Parameswaran H, Fine A and Walsh K: Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol. 294:L1035–L1042. 2008. View Article : Google Scholar : PubMed/NCBI
27	Nakanishi K, Takeda Y, Tetsumoto S, Iwasaki T, Tsujino K, Kuhara H, Jin Y, Nagatomo I, Kida H, Goya S, et al: Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: Implications for therapy. Am J Respir Crit Care Med. 183:1164–1175. 2011. View Article : Google Scholar : PubMed/NCBI
28	Yoon HI, Li Y, Man SF, Tashkin D, Wise RA, Connett JE, Anthonisen NA, Churg A, Wright JL and Sin DD: The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin. Chest. 142:893–899. 2012. View Article : Google Scholar : PubMed/NCBI
29	Chung KF: Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Targets. 7:675–681. 2006. View Article : Google Scholar : PubMed/NCBI
30	Celik H, Akpinar S, Karabulut H, Oktar P, Dursun B, Erguden HC, Gunay S and Sipit T: Evaluation of IL-8 nasal lavage levels and the effects of nasal involvement on disease severity in patients with stable chronic obstructive pulmonary disease. Inflammation. 38:616–622. 2015. View Article : Google Scholar : PubMed/NCBI
31	Antus B and Kardos Z: Oxidative stress in COPD: Molecular background and clinical monitoring. Curr Med Chem. 22:627–650. 2015. View Article : Google Scholar : PubMed/NCBI
32	MacNee W: Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2:50–60. 2005. View Article : Google Scholar : PubMed/NCBI
33	Aoshiba K, Koinuma M, Yokohori N and Nagai A: Immunohistochemical evaluation of oxidative stress in murine lungs after cigarette smoke exposure. Inhal Toxicol. 15:1029–1038. 2003. View Article : Google Scholar : PubMed/NCBI
34	Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T and Matsuzawa Y: Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res. 94:e27–e31. 2004. View Article : Google Scholar : PubMed/NCBI
35	Pang TT and Narendran P: The distribution of adiponectin receptors on human peripheral blood mononuclear cells. Ann N Y Acad Sci. 1150:143–145. 2008. View Article : Google Scholar : PubMed/NCBI
36	Akifusa S, Kamio N, Shimazaki Y, Yamaguchi N and Yamashita Y: Regulation of globular adiponectin-induced apoptosis by reactive oxygen/nitrogen species in RAW264 macrophages. Free Radic Biol Med. 45:1326–1339. 2008. View Article : Google Scholar : PubMed/NCBI
37	Hattori Y, Suzuki M, Hattori S and Kasai K: Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia. 46:1543–1549. 2003. View Article : Google Scholar : PubMed/NCBI
38	Zhao HY, Zhao M, Yi TN and Zhang J: Globular adiponectin protects human umbilical vein endothelial cells against apoptosis through adiponectin receptor 1/adenosine monophosphate-activated protein kinase pathway. Chin Med J (Engl). 124:2540–2547. 2011.PubMed/NCBI